Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 139 articles:
HTML format

Single Articles

    January 2022
  1. KRUGER D, Lahoud N, Yako YY, Devar J, et al
    Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease.
    PLoS One. 2022;17:e0262439.
    PubMed     Abstract available

  2. ALVES FAV, Oliveira LLS, Salomao NG, Provance DW Jr, et al
    Cytokines and inflammatory mediators: Markers involved in interstitial damage to the pancreas in two dengue fever cases associated with acute pancreatitis.
    PLoS One. 2022;17:e0262785.
    PubMed     Abstract available

  3. KARKI B, Thapa S, Khadka D, Karki S, et al
    Intravenous Ringers lactate versus normal saline for predominantly mild acute pancreatitis in a Nepalese Tertiary Hospital.
    PLoS One. 2022;17:e0263221.
    PubMed     Abstract available

  4. Retraction: MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3.
    PLoS One. 2022;17:e0263037.

  5. MUHAMMADZAI J, Haider K, Moser M, Chalchal H, et al
    Early discontinuation of adjuvant chemotherapy in patients with early-stage pancreatic cancer correlates with inferior survival: A multicenter population-based cohort study.
    PLoS One. 2022;17:e0263250.
    PubMed     Abstract available

  6. RYDENFELT K, Strand-Amundsen R, Horneland R, Hodnebo S, et al
    Microdialysis and CO2 sensors detect pancreatic ischemia in a porcine model.
    PLoS One. 2022;17:e0262848.
    PubMed     Abstract available

  7. LUIKEN I, Eisenmann S, Garbe J, Sternby H, et al
    Pleuropulmonary pathologies in the early phase of acute pancreatitis correlate with disease severity.
    PLoS One. 2022;17:e0263739.
    PubMed     Abstract available

  8. VITALE DS, Lahni P, Hornung L, Thompson T, et al
    Matrix metalloproteinases and their inhibitors in pediatric severe acute pancreatitis.
    PLoS One. 2022;17:e0261708.
    PubMed     Abstract available

  9. YAMAI T, Ikezawa K, Hiraga E, Kawamoto Y, et al
    Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel.
    PLoS One. 2022;17:e0264653.
    PubMed     Abstract available

  10. TANIUCHI K, Ueno M, Yokose T, Sakaguchi M, et al
    Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients.
    PLoS One. 2022;17:e0265172.
    PubMed     Abstract available

  11. GARDNER KP, Tsai S, Aldakkak M, Gironda S, et al
    CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer.
    PLoS One. 2022;17:e0264763.
    PubMed     Abstract available

  12. STHIJNS MMJPE, Rademakers T, Oosterveer J, Geuens T, et al
    The response of three-dimensional pancreatic alpha and beta cell co-cultures to oxidative stress.
    PLoS One. 2022;17:e0257578.
    PubMed     Abstract available

  13. DONG Y, Ruano SH, Mishra A, Pennington KA, et al
    Adrenomedullin and its receptors are expressed in mouse pancreatic beta-cells and suppresses insulin synthesis and secretion.
    PLoS One. 2022;17:e0265890.
    PubMed     Abstract available

  14. ARNOLETTI JP, Reza J, Rosales A, Monreal A, et al
    Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation.
    PLoS One. 2022;17:e0265725.
    PubMed     Abstract available

  15. MURATA Y, Ogura T, Hayasaki A, Gyoten K, et al
    Predictive risk factors for early recurrence in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection after preoperative chemoradiotherapy.
    PLoS One. 2022;17:e0264573.
    PubMed     Abstract available

  16. KUMSTEL S, Schreiber T, Goldstein L, Stenzel J, et al
    Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism.
    PLoS One. 2022;17:e0266601.
    PubMed     Abstract available

  17. UWAGAWA T, Sakamoto T, Gocho T, Shiba H, et al
    Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer.
    PLoS One. 2022;17:e0267623.
    PubMed     Abstract available

  18. NURMI AM, Hagstrom J, Mustonen H, Seppanen H, et al
    The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy.
    PLoS One. 2022;17:e0267792.
    PubMed     Abstract available

  19. TAKATS A, Berke G, Gede N, Nemeth BC, et al
    Risk of chronic pancreatitis in carriers of loss-of-function CTRC variants: A meta-analysis.
    PLoS One. 2022;17:e0268859.
    PubMed     Abstract available

  20. YAMAKAWA K, Koyanagi-Aoi M, Uehara K, Masuda A, et al
    Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma.
    PLoS One. 2022;17:e0266620.
    PubMed     Abstract available

  21. THEGE FI, Cardle II, Gruber CN, Siemann MJ, et al
    Acquired chemoresistance drives spatial heterogeneity, chemoprotection and collective migration in pancreatic tumor spheroids.
    PLoS One. 2022;17:e0267882.
    PubMed     Abstract available

  22. IWATATE Y, Yokota H, Hoshino I, Ishige F, et al
    Transcriptomic analysis reveals high ITGB1 expression as a predictor for poor prognosis of pancreatic cancer.
    PLoS One. 2022;17:e0268630.
    PubMed     Abstract available

  23. KASSAY N, Toldi V, Tozser J, Szabo A, et al
    Cigarette smoke toxin hydroquinone and misfolding pancreatic lipase variant cooperatively promote endoplasmic reticulum stress and cell death.
    PLoS One. 2022;17:e0269936.
    PubMed     Abstract available

  24. XU W, Zhang M, Liu L, Yin M, et al
    Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis.
    PLoS One. 2022;17:e0269612.
    PubMed     Abstract available

    January 2021
  25. BARLASS U, Deshmukh A, Beck T, Bishehsari F, et al
    Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases.
    PLoS One. 2021;16:e0244285.
    PubMed     Abstract available

  26. YOSHIOKA R, Imamura H, Ichida H, Gyoda Y, et al
    Simulation training in pancreatico-jejunostomy using an inanimate biotissue model improves the technical skills of hepatobiliary-pancreatic surgical fellows.
    PLoS One. 2021;16:e0244915.
    PubMed     Abstract available

  27. YABE SG, Fukuda S, Nishida J, Takeda F, et al
    Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.
    PLoS One. 2021;16:e0245204.
    PubMed     Abstract available

  28. CHENG K, Liu W, You J, Shah S, et al
    Safety of laparoscopic pancreaticoduodenectomy in patients with liver cirrhosis using propensity score matching.
    PLoS One. 2021;16:e0246364.
    PubMed     Abstract available

  29. XIE J, Peng Y, Chen X, Li Q, et al
    LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
    PLoS One. 2021;16:e0245908.
    PubMed     Abstract available

  30. HOLLENBACH M, Sonnenberg S, Sommerer I, Lorenz J, et al
    Pitfalls in AR42J-model of cerulein-induced acute pancreatitis.
    PLoS One. 2021;16:e0242706.
    PubMed     Abstract available

  31. SOGAWA K, Takano S, Ishige T, Yoshitomi H, et al
    Usefulness of the MALDI-TOF MS technology with membrane filter protocol for the rapid identification of microorganisms in perioperative drainage fluids of hepatobiliary pancreatic surgery.
    PLoS One. 2021;16:e0246002.
    PubMed     Abstract available

  32. MUTHULINGAM JA, Olesen SS, Hansen TM, Brock C, et al
    Cervical transcutaneous vagal neuromodulation in chronic pancreatitis patients with chronic pain: A randomised sham controlled clinical trial.
    PLoS One. 2021;16:e0247653.
    PubMed     Abstract available

  33. LI T, Zhao H, Zhou H, Geng T, et al
    LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
    PLoS One. 2021;16:e0247817.
    PubMed     Abstract available

  34. ZHANG C, Huang L, Xiong J, Xie L, et al
    Isoalantolactone inhibits pancreatic cancer proliferation by regulation of PI3K and Wnt signal pathway.
    PLoS One. 2021;16:e0247752.
    PubMed     Abstract available

  35. CAO H, Qiang L, Chen J, Johnson KM, et al
    Synergistic metalloproteinase-based remodeling of matrix by pancreatic tumor and stromal cells.
    PLoS One. 2021;16:e0248111.
    PubMed     Abstract available

  36. WEYHE D, Obonyo D, Uslar VN, Stricker I, et al
    Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.
    PLoS One. 2021;16:e0248633.
    PubMed     Abstract available

  37. CHENG YH, Chiang EI, Syu JN, Chao CY, et al
    Treatment of 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 inhibits TNF-alpha-mediated expression of MMP-9 protein and cell invasion through the suppression of JNK pathway and microRNA 221 in human pancreatic adenocarcinoma cancer cells.
    PLoS One. 2021;16:e0247550.
    PubMed     Abstract available

  38. SUGAWARA T, Ban D, Nishino J, Watanabe S, et al
    Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection.
    PLoS One. 2021;16:e0249885.
    PubMed     Abstract available

  39. ZHANG W, Sakoda H, Nakazato Y, Islam MN, et al
    Neuromedin U uses Galphai2 and Galphao to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic beta cells.
    PLoS One. 2021;16:e0250232.
    PubMed     Abstract available

  40. ZHONG R, Jiang X, Peng Y, Xu H, et al
    A nomogram prediction of overall survival based on lymph node ratio, AJCC 8th staging system, and other factors for primary pancreatic cancer.
    PLoS One. 2021;16:e0249911.
    PubMed     Abstract available

  41. TARTAGLIONE S, Mancini P, Viggiani V, Chirletti P, et al
    PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma.
    PLoS One. 2021;16:e0251656.
    PubMed     Abstract available

  42. TIAN T, Yang Q, Zhang C, Li X, et al
    MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3.
    PLoS One. 2021;16:e0249375.
    PubMed     Abstract available

  43. ANTWI K, Wiesner P, Merkle EM, Zech CJ, et al
    Investigating difficult to detect pancreatic lesions: Characterization of benign pancreatic islet cell tumors using multiparametric pancreatic 3-T MRI.
    PLoS One. 2021;16:e0253078.
    PubMed     Abstract available

  44. KATO T, Ono H, Fujii M, Akahoshi K, et al
    Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells.
    PLoS One. 2021;16:e0252917.
    PubMed     Abstract available

  45. DHAYAT SA, Tamim ANJ, Jacob M, Ebeling G, et al
    Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients.
    PLoS One. 2021;16:e0252727.
    PubMed     Abstract available

  46. MALHOTRA A, Rachet B, Bonaventure A, Pereira SP, et al
    Can we screen for pancreatic cancer? Identifying a sub-population of patients at high risk of subsequent diagnosis using machine learning techniques applied to primary care data.
    PLoS One. 2021;16:e0251876.
    PubMed     Abstract available

  47. RAJA A, Malik MFA, Haq F
    Genomic relevance of FGF14 and associated genes on the prognosis of pancreatic cancer.
    PLoS One. 2021;16:e0252344.
    PubMed     Abstract available

  48. PEISL S, Mellenthin C, Vignot L, Gonelle-Gispert C, et al
    Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature.
    PLoS One. 2021;16:e0252397.
    PubMed     Abstract available

  49. UDRISTOIU AL, Cazacu IM, Gruionu LG, Gruionu G, et al
    Real-time computer-aided diagnosis of focal pancreatic masses from endoscopic ultrasound imaging based on a hybrid convolutional and long short-term memory neural network model.
    PLoS One. 2021;16:e0251701.
    PubMed     Abstract available

  50. ULLGREN H, Fransson P, Olofsson A, Segersvard R, et al
    Health care utilization at end of life among patients with lung or pancreatic cancer. Comparison between two Swedish cohorts.
    PLoS One. 2021;16:e0254673.
    PubMed     Abstract available

  51. ITO G, Kawakami K, Aoyama T, Yokokawa T, et al
    Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy.
    PLoS One. 2021;16:e0254726.
    PubMed     Abstract available

  52. STREICHER SA, Lim U, Park SL, Li Y, et al
    Genome-wide association study of pancreatic fat: The Multiethnic Cohort Adiposity Phenotype Study.
    PLoS One. 2021;16:e0249615.
    PubMed     Abstract available

  53. IMURA T, Inagaki A, Igarashi Y, Goto M, et al
    Optimization of dye solutions for detecting damaged pancreatic tissues during islet isolation procedures.
    PLoS One. 2021;16:e0255733.
    PubMed     Abstract available

  54. KAFITA D, Nkhoma P, Zulu M, Sinkala M, et al
    Proteogenomic analysis of pancreatic cancer subtypes.
    PLoS One. 2021;16:e0257084.
    PubMed     Abstract available

  55. BARKO PC, Williams DA
    Untargeted analysis of the serum metabolome in cats with exocrine pancreatic insufficiency.
    PLoS One. 2021;16:e0257856.
    PubMed     Abstract available

  56. GAO Y, Wang M, Guo X, Hu J, et al
    Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma.
    PLoS One. 2021;16:e0250539.
    PubMed     Abstract available

  57. WESTENFELDER C, Hu Z, Zhang P, Gooch A, et al
    Intraperitoneal administration of human "Neo-Islets", 3-D organoids of mesenchymal stromal and pancreatic islet cells, normalizes blood glucose levels in streptozotocin-diabetic NOD/SCID mice: Significance for clinical trials.
    PLoS One. 2021;16:e0259043.
    PubMed     Abstract available

  58. WAKIYA T, Ishido K, Kimura N, Nagase H, et al
    Prediction of massive bleeding in pancreatic surgery based on preoperative patient characteristics using a decision tree.
    PLoS One. 2021;16:e0259682.
    PubMed     Abstract available

  59. MAEDA K, Kuriyama N, Nakagawa Y, Ito T, et al
    Optimal management of peripancreatic fluid collection with postoperative pancreatic fistula after distal pancreatectomy: Significance of computed tomography values for predicting fluid infection.
    PLoS One. 2021;16:e0259701.
    PubMed     Abstract available

  60. XU YF, Xu X, Bhandari K, Gin A, et al
    Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs.
    PLoS One. 2021;16:e0259563.
    PubMed     Abstract available

  61. JANG DK, Ahn DW, Lee KL, Kim BG, et al
    Impacts of body composition parameters and liver cirrhosis on the severity of alcoholic acute pancreatitis.
    PLoS One. 2021;16:e0260309.
    PubMed     Abstract available

  62. LI X, Yang Q, Ye H, Li S, et al
    Comparison of pancreatic fat content measured by different methods employing MR mDixon sequence.
    PLoS One. 2021;16:e0260001.
    PubMed     Abstract available

  63. PULIPATI VP, Amblee A, Yap SET, Shaka H, et al
    Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion.
    PLoS One. 2021;16:e0260495.
    PubMed     Abstract available

  64. CHERUBINI A, Rusconi F, Lazzari L
    Identification of the best housekeeping gene for RT-qPCR analysis of human pancreatic organoids.
    PLoS One. 2021;16:e0260902.
    PubMed     Abstract available

  65. WEEGH N, Zentrich E, Zechner D, Struve B, et al
    Voluntary wheel running behaviour as a tool to assess the severity in a mouse pancreatic cancer model.
    PLoS One. 2021;16:e0261662.
    PubMed     Abstract available

  66. WURTZEL JGT, Lazar S, Sikder S, Cai KQ, et al
    Platelet microRNAs inhibit primary tumor growth via broad modulation of tumor cell mRNA expression in ectopic pancreatic cancer in mice.
    PLoS One. 2021;16:e0261633.
    PubMed     Abstract available

  67. PHILLIP V, Schwab M, Haf D, Algul H, et al
    Correction: Identification of risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis in a high volume center.
    PLoS One. 2021;16:e0261576.
    PubMed     Abstract available

    January 2020
  68. OHKUMA R, Yada E, Ishikawa S, Komura D, et al
    High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
    PLoS One. 2020;15:e0226707.
    PubMed     Abstract available

  69. PLAYFORD RJ, Marchbank T
    Pancreatic secretory trypsin inhibitor reduces multi-organ injury caused by gut ischemia/reperfusion in mice.
    PLoS One. 2020;15:e0227059.
    PubMed     Abstract available

  70. BROWN M, Zhang W, Yan D, Kenath R, et al
    The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC.
    PLoS One. 2020;15:e0226917.
    PubMed     Abstract available

  71. ANDO Y, Ohuchida K, Otsubo Y, Kibe S, et al
    Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5.
    PLoS One. 2020;15:e0228015.
    PubMed     Abstract available

  72. SINGH S, McDonald JT, Ilie G, Adisesh A, et al
    An examination of the association between lifetime history of prostate and pancreatic cancer diagnosis and occupation in a population sample of Canadians.
    PLoS One. 2020;15:e0227622.
    PubMed     Abstract available

  73. KHILJI MS, Verstappen D, Dahlby T, Burstein Prause MC, et al
    The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 beta.
    PLoS One. 2020;15:e0222432.
    PubMed     Abstract available

  74. Expression of Concern: Reduction in ATP Levels Triggers Immunoproteasome Activation by the 11S (PA28) Regulator during Early Antiviral Response Mediated by IFNbeta in Mouse Pancreatic beta-Cells.
    PLoS One. 2020;15:e0229516.

  75. SOLANKI A, King D, Thibault G, Wang L, et al
    Quantification of fluorophore distribution and therapeutic response in matched in vivo and ex vivo pancreatic cancer model systems.
    PLoS One. 2020;15:e0229407.
    PubMed     Abstract available

  76. USON PLS JUNIOR, Tolentino FDS, Santos VM, Rother ET, et al
    The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies.
    PLoS One. 2020;15:e0230060.
    PubMed     Abstract available

  77. WOLFE D, Kanji S, Yazdi F, Barbeau P, et al
    Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.
    PLoS One. 2020;15:e0231883.
    PubMed     Abstract available

  78. FANCHON LM, Russell J, Pillarsetty N, O'Donoghue I, et al
    Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0231745.
    PubMed     Abstract available

  79. BUSTOS AS, Hakansson A, Linares-Pasten JA, Penarrieta JM, et al
    Interaction of quercetin and epigallocatechin gallate (EGCG) aggregates with pancreatic lipase under simplified intestinal conditions.
    PLoS One. 2020;15:e0224853.
    PubMed     Abstract available

  80. DEMIRKOL CANLI S, Dedeoglu E, Akbar MW, Kucukkaraduman B, et al
    A novel 20-gene prognostic score in pancreatic adenocarcinoma.
    PLoS One. 2020;15:e0231835.
    PubMed     Abstract available

  81. CHOW JPH, Cai Y, Chow DTL, Chung SHK, et al
    A modified arginine-depleting enzyme NEI-01 inhibits growth of pancreatic cancer cells.
    PLoS One. 2020;15:e0231633.
    PubMed     Abstract available

  82. LUO S, Lenon GB, Gill H, Hung A, et al
    Inhibitory effect of a weight-loss Chinese herbal formula RCM-107 on pancreatic alpha-amylase activity: Enzymatic and in silico approaches.
    PLoS One. 2020;15:e0231815.
    PubMed     Abstract available

  83. TAKENAGA K, Akimoto M, Koshikawa N, Nagase H, et al
    Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model.
    PLoS One. 2020;15:e0232230.
    PubMed     Abstract available

  84. Retraction: Concomitant Targeting of EGF Receptor, TGF-beta and Src Points to a Novel Therapeutic Approach in Pancreatic Cancer.
    PLoS One. 2020;15:e0233436.

  85. Expression of Concern: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.
    PLoS One. 2020;15:e0233098.

  86. LAI HC, Lee MS, Liu YT, Lin KT, et al
    Propofol-based intravenous anesthesia is associated with better survival than desflurane anesthesia in pancreatic cancer surgery.
    PLoS One. 2020;15:e0233598.
    PubMed     Abstract available

  87. HARADA N, Nomura M, Yoda Y, Matsumura S, et al
    Food texture affects glucose tolerance by altering pancreatic beta-cell function in mice consuming high-fructose corn syrup.
    PLoS One. 2020;15:e0233797.
    PubMed     Abstract available

  88. CHOU CK, Lee KC, Luo JC, Chen TS, et al
    Endoscopic papillary balloon dilatation less than three minutes for biliary stone removal increases the risk of post-ERCP pancreatitis.
    PLoS One. 2020;15:e0233388.
    PubMed     Abstract available

  89. SHINJO K, Hara K, Nagae G, Umeda T, et al
    A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
    PLoS One. 2020;15:e0233782.
    PubMed     Abstract available

  90. ABU-SHAWER O, Abu-Shawer M, Shurman A, Lattouf A, et al
    The clinical value of peripheral immune cell counts in pancreatic cancer.
    PLoS One. 2020;15:e0232043.
    PubMed     Abstract available

  91. KLAK M, Gomolka M, Dobrzanski T, Tymicki G, et al
    Irradiation with 365 nm and 405 nm wavelength shows differences in DNA damage of swine pancreatic islets.
    PLoS One. 2020;15:e0235052.
    PubMed     Abstract available

  92. UESATO Y, Sasahira N, Ozaka M, Sasaki T, et al
    Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis.
    PLoS One. 2020;15:e0235623.
    PubMed     Abstract available

  93. SATO K, Hikita H, Myojin Y, Fukumoto K, et al
    Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levels.
    PLoS One. 2020;15:e0235573.
    PubMed     Abstract available

  94. SHINOURA S, Tokushige A, Chinen K, Mori H, et al
    Endosonographic finding of the simultaneous depiction of bile and pancreatic ducts can predict difficult biliary cannulation on endoscopic retrograde cholangiopancreatography.
    PLoS One. 2020;15:e0235757.
    PubMed     Abstract available

  95. SUZUKI Y, Takadate T, Mizuma M, Shima H, et al
    Stromal expression of hemopexin is associated with lymph-node metastasis in pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0235904.
    PubMed     Abstract available

  96. BOLM L, Zghurskyi P, Lapshyn H, Petrova E, et al
    Alignment of stroma fibers, microvessel density and immune cell populations determine overall survival in pancreatic cancer-An analysis of stromal morphology.
    PLoS One. 2020;15:e0234568.
    PubMed     Abstract available

  97. MOGENSEN PR, Grell K, Schmiegelow K, Overgaard UM, et al
    Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia.
    PLoS One. 2020;15:e0231209.
    PubMed     Abstract available

  98. MIYAKE H, Sakagami J, Yasuda H, Sogame Y, et al
    Correction: Association of fatty pancreas with pancreatic endocrine and exocrine function.
    PLoS One. 2020;15:e0236915.
    PubMed     Abstract available

  99. TAKAHASHI M, Shibasaki M, Echizen H, Kushiyama A, et al
    Comparisons between dipeptidyl peptidase-4 inhibitors and other classes of hypoglycemic drugs using two distinct biomarkers of pancreatic beta-cell function: A meta-analysis.
    PLoS One. 2020;15:e0236603.
    PubMed     Abstract available

  100. HAL WA, Straza MW, Chen X, Mickevicius N, et al
    Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    PLoS One. 2020;15:e0236570.
    PubMed     Abstract available

  101. XIE F, Chen Q, Zhou Y, Chen W, et al
    Characterization of patients with advanced chronic pancreatitis using natural language processing of radiology reports.
    PLoS One. 2020;15:e0236817.
    PubMed     Abstract available

  102. UHLEMEYER C, Muller N, Griess K, Wessel C, et al
    ATM and P53 differentially regulate pancreatic beta cell survival in Ins1E cells.
    PLoS One. 2020;15:e0237669.
    PubMed     Abstract available

  103. BERNARD B, Rajamanickam V, Dubay C, Piening B, et al
    Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer.
    PLoS One. 2020;15:e0238380.
    PubMed     Abstract available

  104. LEE J, Lee JC, Kim HW, Kim J, et al
    Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer.
    PLoS One. 2020;15:e0238649.
    PubMed     Abstract available

  105. MARGARYAN S, Kriegova E, Fillerova R, Smotkova Kraiczova V, et al
    Hypomethylation of IL1RN and NFKB1 genes is linked to the dysbalance in IL1beta/IL-1Ra axis in female patients with type 2 diabetes mellitus.
    PLoS One. 2020;15:e0233737.
    PubMed     Abstract available

  106. BOAS FE, Nurili F, Bendet A, Cheleuitte-Nieves C, et al
    Induction and characterization of pancreatic cancer in a transgenic pig model.
    PLoS One. 2020;15:e0239391.
    PubMed     Abstract available

  107. CHOI MH, Yoon SB, Song M, Lee IS, et al
    Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography.
    PLoS One. 2020;15:e0240318.
    PubMed     Abstract available

  108. NWEKE EE, Naicker P, Aron S, Stoychev S, et al
    SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathways.
    PLoS One. 2020;15:e0240453.
    PubMed     Abstract available

  109. YAMAMOTO S, Nagamine Y, Miyashita T, Ito S, et al
    Perioperative and anesthetic risk factors of surgical site infection in patients undergoing pancreaticoduodenectomy: A retrospective cohort study.
    PLoS One. 2020;15:e0240490.
    PubMed     Abstract available

  110. PAVLIKOVA N, Sramek J, Jelinek M, Halada P, et al
    Markers of acute toxicity of DDT exposure in pancreatic beta-cells determined by a proteomic approach.
    PLoS One. 2020;15:e0229430.
    PubMed     Abstract available

  111. CEBALLOS GA, Hernandez LF, Paredes D, Betancourt LR, et al
    A machine learning approach to predict pancreatic islet grafts rejection versus tolerance.
    PLoS One. 2020;15:e0241925.
    PubMed     Abstract available

  112. Correction: Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    PLoS One. 2020;15:e0242146.
    PubMed     Abstract available

  113. HUNG WC, Lee DY, Chiang EI, Syu JN, et al
    Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis.
    PLoS One. 2020;15:e0241186.
    PubMed     Abstract available

  114. THAKAR M, Hu Y, Morreale M, Lerner L, et al
    Correction: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent.
    PLoS One. 2020;15:e0242974.
    PubMed     Abstract available

  115. SHEIKH M, Masoudi S, Bakhshandeh R, Moayyedkazemi A, et al
    Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
    PLoS One. 2020;15:e0243511.
    PubMed     Abstract available

  116. ROH YH, Kang BK, Song SY, Lee CM, et al
    Preoperative CT anthropometric measurements and pancreatic pathology increase risk for postoperative pancreatic fistula in patients following pancreaticoduodenectomy.
    PLoS One. 2020;15:e0243515.
    PubMed     Abstract available

  117. WOCHNER R, Clauss D, Nattenmuller J, Tjaden C, et al
    Impact of progressive resistance training on CT quantified muscle and adipose tissue compartments in pancreatic cancer patients.
    PLoS One. 2020;15:e0242785.
    PubMed     Abstract available

  118. DOI N, Ino Y, Angata K, Shimada K, et al
    Clinicopathological significance of core 3 O-glycan synthetic enzyme, beta1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0242851.
    PubMed     Abstract available

  119. GASTEIGER S, Primavesi F, Werkl P, Dostal L, et al
    The prognostic value of Presepsin for postoperative complications following pancreatic resection: A prospective study.
    PLoS One. 2020;15:e0243510.
    PubMed     Abstract available

  120. DUORUI N, Shi B, Zhang T, Chen C, et al
    The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: A population-based study.
    PLoS One. 2020;15:e0243164.
    PubMed     Abstract available

  121. MAHARAJ AD, Evans SM, Zalcberg JR, Ioannou LJ, et al
    Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework.
    PLoS One. 2020;15:e0243312.
    PubMed     Abstract available

  122. LIN ZB, Song JY, Li AC, Chen C, et al
    The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis.
    PLoS One. 2020;15:e0243170.
    PubMed     Abstract available

  123. RAJPUT SA, Mirza MR, Choudhary MI
    Bergenin protects pancreatic beta cells against cytokine-induced apoptosis in INS-1E cells.
    PLoS One. 2020;15:e0241349.
    PubMed     Abstract available

  124. GRUBER ES, Jomrich G, Tamandl D, Gnant M, et al
    Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0244896.
    PubMed     Abstract available

  125. CHEN CY, Liang SH, Su YY, Chiang NJ, et al
    Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan.
    PLoS One. 2020;15:e0244487.
    PubMed     Abstract available

    January 2019
  126. KAISSIS G, Ziegelmayer S, Lohofer F, Steiger K, et al
    A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy.
    PLoS One. 2019;14:e0218642.
    PubMed     Abstract available

  127. KELLAWAY SG, Mosinska K, Mohamed Z, Ryan A, et al
    Correction: Increased proliferation and altered cell cycle regulation in pancreatic stem cells derived from patients with congenital hyperinsulinism.
    PLoS One. 2019;14:e0223999.
    PubMed     Abstract available

  128. SANKAR KS, Altamentova SM, Rocheleau JV
    Hypoxia induction in cultured pancreatic islets enhances endothelial cell morphology and survival while maintaining beta-cell function.
    PLoS One. 2019;14:e0222424.
    PubMed     Abstract available

  129. AIER I, Semwal R, Dhara A, Sen N, et al
    An integrated epigenome and transcriptome analysis identifies PAX2 as a master regulator of drug resistance in high grade pancreatic ductal adenocarcinoma.
    PLoS One. 2019;14:e0223554.
    PubMed     Abstract available

  130. KOBAYASHI M, Ryozawa S, Iwano H, Araki R, et al
    The usefulness of wire-guided endoscopic snare papillectomy for tumors of the major duodenal papilla.
    PLoS One. 2019;14:e0211019.
    PubMed     Abstract available

  131. KAUNE T, Hollenbach M, Keil B, Chen JM, et al
    Common variants in glyoxalase I do not increase chronic pancreatitis risk.
    PLoS One. 2019;14:e0222927.
    PubMed     Abstract available

  132. Expression of Concern: Cooperativity of Oncogenic K-Ras and Downregulated p16/INK4A in Human Pancreatic Tumorigenesis.
    PLoS One. 2019;14:e0225279.

  133. JANG E, Son M, Jang J, Lee IH, et al
    DHP23002 as a next generation oral paclitaxel formulation for pancreatic cancer therapy.
    PLoS One. 2019;14:e0225095.
    PubMed     Abstract available

  134. KATO S, Iwasaki A, Kurita Y, Arimoto J, et al
    Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility.
    PLoS One. 2019;14:e0224921.
    PubMed     Abstract available

  135. KUBO K, Wadasaki K, Komichi D, Sasaki T, et al
    A single institution experience of the treatment of pancreatic ductal carcinoma: The demand and the role of radiation therapy.
    PLoS One. 2019;14:e0227305.
    PubMed     Abstract available

  136. PARK D, Shakya R, Koivisto C, Pitarresi JR, et al
    Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains.
    PLoS One. 2019;14:e0226714.
    PubMed     Abstract available

  137. ALNAHDI A, John A, Raza H
    N-acetyl cysteine attenuates oxidative stress and glutathione-dependent redox imbalance caused by high glucose/high palmitic acid treatment in pancreatic Rin-5F cells.
    PLoS One. 2019;14:e0226696.
    PubMed     Abstract available

  138. ZHENG Z, Wang M, Tan C, Chen Y, et al
    Disparities in survival by stage after surgery between pancreatic head and body/tail in patients with nonmetastatic pancreatic cancer.
    PLoS One. 2019;14:e0226726.
    PubMed     Abstract available

  139. WATANABE F, Suzuki K, Tamaki S, Abe I, et al
    Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer.
    PLoS One. 2019;14:e0227366.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.